Cargando…

Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19

Detalles Bibliográficos
Autores principales: Leef, Chelsea, Horton, Codi, Lee, Tricia, Lee, Gerald, Tison, Katherine, Vickery, Brian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576059/
https://www.ncbi.nlm.nih.gov/pubmed/34763124
http://dx.doi.org/10.1016/j.jaip.2021.08.044
_version_ 1784595806883414016
author Leef, Chelsea
Horton, Codi
Lee, Tricia
Lee, Gerald
Tison, Katherine
Vickery, Brian P.
author_facet Leef, Chelsea
Horton, Codi
Lee, Tricia
Lee, Gerald
Tison, Katherine
Vickery, Brian P.
author_sort Leef, Chelsea
collection PubMed
description
format Online
Article
Text
id pubmed-8576059
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-85760592021-11-09 Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19 Leef, Chelsea Horton, Codi Lee, Tricia Lee, Gerald Tison, Katherine Vickery, Brian P. J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-01 2021-11-09 /pmc/articles/PMC8576059/ /pubmed/34763124 http://dx.doi.org/10.1016/j.jaip.2021.08.044 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Communications
Leef, Chelsea
Horton, Codi
Lee, Tricia
Lee, Gerald
Tison, Katherine
Vickery, Brian P.
Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title_full Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title_fullStr Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title_full_unstemmed Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title_short Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19
title_sort exploring barriers to commercial peanut oral immunotherapy treatment during covid-19
topic Clinical Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576059/
https://www.ncbi.nlm.nih.gov/pubmed/34763124
http://dx.doi.org/10.1016/j.jaip.2021.08.044
work_keys_str_mv AT leefchelsea exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19
AT hortoncodi exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19
AT leetricia exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19
AT leegerald exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19
AT tisonkatherine exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19
AT vickerybrianp exploringbarrierstocommercialpeanutoralimmunotherapytreatmentduringcovid19